Skip to main content
. 2018 May 22;9(39):25529–25544. doi: 10.18632/oncotarget.25368

Table 1. Selinexor IC50.

Selinexor
IC50
Selinexor IC50
(in the presence of Dexamethasone)
Dexamethasone
@ IC25
10 μM
Dexamethasone
MM.1S 40 nM 11 nM < 0.15 nM
H929 220 nM 30 nM 4.6 nM
MM.1R 50 nM N/A 57 nM

MM.1S, H929, MM.1R cells were treated with different concentrations of selinexor alone or in the presence of DEX at IC25 or 10 μM for 72 hrs. DEX at IC25 reduced the of IC50 selinexor’s by 3.7 fold and 7.3 fold for MM.1S and H929 cells, respectively, but had no effect on GRnull MM.1R cells even at 10 μM.